300519 新光药业
交易中 11-22 14:41:00
资讯
新帖
简况
新光药业(300519)2024年三季报简析:增收不增利
证券之星 · 10-25
新光药业(300519)2024年三季报简析:增收不增利
图解新光药业三季报:第三季度单季净利润同比减39.11%
证券之星 · 10-23
图解新光药业三季报:第三季度单季净利润同比减39.11%
新光药业(300519.SZ)发布前三季度业绩,净利润3778.24万元,同比下降35.63%
智通财经 · 10-23
新光药业(300519.SZ)发布前三季度业绩,净利润3778.24万元,同比下降35.63%
新光药业(300519)10月23日主力资金净卖出1494.21万元
证券之星 · 10-23
新光药业(300519)10月23日主力资金净卖出1494.21万元
新光药业(300519)10月22日主力资金净买入1003.78万元
证券之星 · 10-22
新光药业(300519)10月22日主力资金净买入1003.78万元
新光药业(300519)10月11日主力资金净卖出686.32万元
证券之星 · 10-11
新光药业(300519)10月11日主力资金净卖出686.32万元
异动快报:新光药业(300519)10月8日14点25分触及涨停板
证券之星 · 10-08
异动快报:新光药业(300519)10月8日14点25分触及涨停板
新光药业(300519)9月30日主力资金净买入886.90万元
证券之星 · 09-30
新光药业(300519)9月30日主力资金净买入886.90万元
新光药业(300519)2024年中报简析:净利润减33.81%
证券之星 · 08-28
新光药业(300519)2024年中报简析:净利润减33.81%
图解新光药业中报:第二季度单季净利润同比减66.92%
证券之星 · 08-27
图解新光药业中报:第二季度单季净利润同比减66.92%
新光药业最新公告:上半年净利润同比下降33.81%
证券之星 · 08-26
新光药业最新公告:上半年净利润同比下降33.81%
新光药业(300519.SZ)发布上半年业绩,净利润2550.77万元,下降33.81%
智通财经网 · 08-26
新光药业(300519.SZ)发布上半年业绩,净利润2550.77万元,下降33.81%
新光药业:公司一直致力于营销网络的建设,致力于销售渠道的建设与维护
证券之星 · 08-21
新光药业:公司一直致力于营销网络的建设,致力于销售渠道的建设与维护
新光药业(300519)8月19日主力资金净卖出380.27万元
证券之星 · 08-19
新光药业(300519)8月19日主力资金净卖出380.27万元
新光药业(300519)8月14日主力资金净卖出107.88万元
证券之星 · 08-14
新光药业(300519)8月14日主力资金净卖出107.88万元
新光药业(300519)8月12日主力资金净买入1122.86万元
证券之星 · 08-12
新光药业(300519)8月12日主力资金净买入1122.86万元
新光药业(300519)8月9日主力资金净卖出1027.76万元
证券之星 · 08-09
新光药业(300519)8月9日主力资金净卖出1027.76万元
新光药业(300519)8月7日主力资金净卖出384.18万元
证券之星 · 08-07
新光药业(300519)8月7日主力资金净卖出384.18万元
新光药业(300519)8月6日主力资金净买入582.90万元
证券之星 · 08-06
新光药业(300519)8月6日主力资金净买入582.90万元
A股中药股震荡走强,佛慈制药午后涨停,华森制药、维康药业、长药控股、健民集团涨超5%,新光药业、盘龙药业、大唐药业、粤万年青等跟涨。
美港电讯 · 08-06
A股中药股震荡走强,佛慈制药午后涨停,华森制药、维康药业、长药控股、健民集团涨超5%,新光药业、盘龙药业、大唐药业、粤万年青等跟涨。
加载更多
公司概况
公司名称:
浙江新光药业股份有限公司
所属行业:
医药制造业
上市日期:
2016-06-24
主营业务:
浙江新光药业股份有限公司的主营业务是中成药、化学药、保健食品的研发、生产和销售。公司主要产品以治疗心脑血管疾病、外伤科疾病和保健滋补为主,主要产品为黄芪生脉饮、伸筋丹胶囊、西洋参口服液等。由于公司对产品质量严格要求,公司主导产品黄芪生脉饮多次获得“浙江省名牌产品”称号和“中国中药名牌产品”称号,为公司赢得了良好的品牌形象。
发行价格:
12.20
{"stockData":{"symbol":"300519","market":"SZ","secType":"STK","nameCN":"新光药业","latestPrice":14.04,"timestamp":1732257660000,"preClose":14.75,"halted":0,"volume":2458400,"delay":0,"floatShares":113999999,"shares":160000000,"eps":0.2715,"marketStatus":"交易中","marketStatusCode":2,"change":-0.71,"latestTime":"11-22 14:41:00","open":14.79,"high":14.79,"low":14.01,"amount":35346100,"amplitude":0.0529,"askPrice":14.04,"askSize":336,"bidPrice":14.03,"bidSize":4,"shortable":0,"etf":0,"ttmEps":0.2715,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732258800000},"adr":0,"adjPreClose":14.75,"symbolType":"stock","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":16.23,"lowLimit":13.28,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":160000000,"pbRate":2.89,"roa":"--","roe":"4.53%","epsLYR":0.4,"committee":0.547489,"marketValue":2246000000,"floatMarketCap":1602000000,"peRate":51.712709,"changeRate":-0.0481,"turnoverRate":0.0215,"status":1},"requestUrl":"/m/hq/s/300519","defaultTab":"news","newsList":[{"id":"2478692002","title":"新光药业(300519)2024年三季报简析:增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2478692002","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478692002?lang=zh_cn&edition=full","pubTime":"2024-10-25 06:08","pubTimestamp":1729807697,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期新光药业发布2024年三季报。根据财报显示,新光药业增收不增利。截至本报告期末,公司营业总收入2.16亿元,同比上升0.05%,归母净利润3778.24万元,同比下降35.63%。按单季度数据看,第三季度营业总收入7000.14万元,同比上升4.36%,第三季度归母净利润1227.47万元,同比下降39.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500005282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300519","BK0132"],"gpt_icon":0},{"id":"2477237042","title":"图解新光药业三季报:第三季度单季净利润同比减39.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477237042","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477237042?lang=zh_cn&edition=full","pubTime":"2024-10-23 16:47","pubTimestamp":1729673228,"startTime":"0","endTime":"0","summary":"证券之星消息,新光药业2024年三季报显示,公司主营收入2.16亿元,同比上升0.05%;归母净利润3778.24万元,同比下降35.63%;扣非净利润3455.37万元,同比下降37.55%;其中2024年第三季度,公司单季度主营收入7000.14万元,同比上升4.36%;单季度归母净利润1227.47万元,同比下降39.11%;单季度扣非净利润1197.92万元,同比下降38.86%;负债率8.35%,投资收益361.69万元,财务费用-431.27万元,毛利率35.08%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102300027175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300519"],"gpt_icon":0},{"id":"2477371092","title":"新光药业(300519.SZ)发布前三季度业绩,净利润3778.24万元,同比下降35.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477371092","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477371092?lang=zh_cn&edition=full","pubTime":"2024-10-23 16:09","pubTimestamp":1729670996,"startTime":"0","endTime":"0","summary":"智通财经APP讯,新光药业(300519.SZ)发布2024年三季度报告,前三季度,公司实现营业收入2.16亿元,同比增长0.05%。归属于上市公司股东的净利润3778.24万元,同比下降35.63%。归属于上市公司股东的扣除非经常性损益的净利润3455.37万元,同比下降37.55%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1197954.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300519"],"gpt_icon":0},{"id":"2477375156","title":"新光药业(300519)10月23日主力资金净卖出1494.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477375156","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477375156?lang=zh_cn&edition=full","pubTime":"2024-10-23 15:23","pubTimestamp":1729668239,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月23日收盘,新光药业报收于14.96元,下跌3.36%,换手率7.55%,成交量8.62万手,成交额1.29亿元。10月23日的资金流向数据方面,主力资金净流出1494.21万元,占总成交额11.56%,游资资金净流出20.49万元,占总成交额0.16%,散户资金净流入1514.71万元,占总成交额11.72%。新光药业主营业务:主要从事中成药、化学药、保健食品的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102300019739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300519","BK0132"],"gpt_icon":0},{"id":"2477033068","title":"新光药业(300519)10月22日主力资金净买入1003.78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477033068","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477033068?lang=zh_cn&edition=full","pubTime":"2024-10-22 15:21","pubTimestamp":1729581700,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月22日收盘,新光药业报收于15.48元,上涨5.09%,换手率12.03%,成交量13.73万手,成交额2.14亿元。10月22日的资金流向数据方面,主力资金净流入1003.78万元,占总成交额4.69%,游资资金净流出161.96万元,占总成交额0.76%,散户资金净流出841.82万元,占总成交额3.93%。新光药业主营业务:主要从事中成药、化学药、保健食品的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200018208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","300519"],"gpt_icon":0},{"id":"2474551290","title":"新光药业(300519)10月11日主力资金净卖出686.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474551290","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474551290?lang=zh_cn&edition=full","pubTime":"2024-10-11 15:23","pubTimestamp":1728631438,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月11日收盘,新光药业报收于13.55元,下跌8.82%,换手率9.33%,成交量10.64万手,成交额1.47亿元。10月11日的资金流向数据方面,主力资金净流出686.32万元,占总成交额4.68%,游资资金净流出665.94万元,占总成交额4.54%,散户资金净流入1352.27万元,占总成交额9.21%。新光药业主营业务:主要从事中成药、化学药、保健食品的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101100017049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300519","BK0239"],"gpt_icon":0},{"id":"2473497073","title":"异动快报:新光药业(300519)10月8日14点25分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2473497073","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473497073?lang=zh_cn&edition=full","pubTime":"2024-10-08 14:25","pubTimestamp":1728368731,"startTime":"0","endTime":"0","summary":"证券之星10月8日盘中消息,14点25分新光药业(300519)触及涨停板。目前价格17.02,上涨20.03%。其所属行业中药目前上涨。领涨股为新光药业。该股为肝炎概念,医药,保健品概念热股,当日肝炎概念概念上涨6.65%,医药概念上涨4.71%,保健品概念上涨4.02%。9月30日的资金流向数据方面,主力资金净流入886.9万元,占总成交额6.43%,游资资金净流入921.21万元,占总成交额6.68%,散户资金净流出1808.11万元,占总成交额13.11%。近5日资金流向一览见下表:新光药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100800015090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","300519"],"gpt_icon":0},{"id":"2471331821","title":"新光药业(300519)9月30日主力资金净买入886.90万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471331821","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471331821?lang=zh_cn&edition=full","pubTime":"2024-09-30 15:24","pubTimestamp":1727681048,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月30日收盘,新光药业报收于14.18元,上涨18.07%,换手率9.24%,成交量10.54万手,成交额1.38亿元。9月30日的资金流向数据方面,主力资金净流入886.9万元,占总成交额6.43%,游资资金净流入921.21万元,占总成交额6.68%,散户资金净流出1808.11万元,占总成交额13.11%。新光药业主营业务:主要从事中成药、化学药、保健食品的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024093000021692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","300519"],"gpt_icon":0},{"id":"2462128000","title":"新光药业(300519)2024年中报简析:净利润减33.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462128000","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462128000?lang=zh_cn&edition=full","pubTime":"2024-08-28 06:23","pubTimestamp":1724797399,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期新光药业发布2024年中报。根据财报显示,新光药业净利润减33.81%。截至本报告期末,公司营业总收入1.46亿元,同比下降1.9%,归母净利润2550.77万元,同比下降33.81%。按单季度数据看,第二季度营业总收入4566.48万元,同比下降19.52%,第二季度归母净利润267.73万元,同比下降66.92%。净利润变动幅度为-33.81%,原因:报告期内原药材价格上涨,成本上升。归属于母公司所有者的综合收益总额变动幅度为-34.98%,原因:报告期内净利润较上年同期减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800007671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300519"],"gpt_icon":0},{"id":"2462470949","title":"图解新光药业中报:第二季度单季净利润同比减66.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462470949","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462470949?lang=zh_cn&edition=full","pubTime":"2024-08-27 01:28","pubTimestamp":1724693305,"startTime":"0","endTime":"0","summary":"证券之星消息,新光药业2024年中报显示,公司主营收入1.46亿元,同比下降1.9%;归母净利润2550.77万元,同比下降33.81%;扣非净利润2257.45万元,同比下降36.83%;其中2024年第二季度,公司单季度主营收入4566.48万元,同比下降19.52%;单季度归母净利润267.73万元,同比下降66.92%;单季度扣非净利润123.25万元,同比下降79.68%;负债率8.59%,投资收益248.99万元,财务费用-385.54万元,毛利率34.0%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082700001902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300519"],"gpt_icon":0},{"id":"2462776961","title":"新光药业最新公告:上半年净利润同比下降33.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462776961","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462776961?lang=zh_cn&edition=full","pubTime":"2024-08-26 17:49","pubTimestamp":1724665789,"startTime":"0","endTime":"0","summary":"新光药业发布2024年半年度报告,报告期内公司实现营业收入1.46亿元,同比下降1.90%;归属于上市公司股东的净利润2550.77万元,同比下降33.81%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082600025039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300519"],"gpt_icon":0},{"id":"2462961193","title":"新光药业(300519.SZ)发布上半年业绩,净利润2550.77万元,下降33.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462961193","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462961193?lang=zh_cn&edition=full","pubTime":"2024-08-26 17:45","pubTimestamp":1724665542,"startTime":"0","endTime":"0","summary":"智通财经APP讯,新光药业(300519.SZ)发布2024年半年度报告,该公司营业收入为1.46亿元,同比减少1.90%。归属于上市公司股东的净利润为2550.77万元,同比减少33.81%。归属于上市公司股东的扣除非经常性损益的净利润为2257.45万元,同比减少36.83%。基本每股收益为0.16元。报告期内原药材价格上涨,成本上升。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1170652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300519"],"gpt_icon":0},{"id":"2461986812","title":"新光药业:公司一直致力于营销网络的建设,致力于销售渠道的建设与维护","url":"https://stock-news.laohu8.com/highlight/detail?id=2461986812","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461986812?lang=zh_cn&edition=full","pubTime":"2024-08-21 17:10","pubTimestamp":1724231432,"startTime":"0","endTime":"0","summary":"证券之星消息,新光药业08月21日在投资者关系平台上答复投资者关心的问题。开发新的销售市场渠道?公司一直致力于营销网络的建设,致力于销售渠道的建设与维护。我们会将您的建议向公司董事会反馈。相关情况请关注公司定期报告。公司与浙二医院的合作项目处于正常开展中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082100030719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","300519"],"gpt_icon":0},{"id":"2460069677","title":"新光药业(300519)8月19日主力资金净卖出380.27万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460069677","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460069677?lang=zh_cn&edition=full","pubTime":"2024-08-19 15:24","pubTimestamp":1724052281,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月19日收盘,新光药业报收于12.12元,下跌3.96%,换手率4.36%,成交量4.97万手,成交额6056.38万元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:新光药业2024年一季报显示,公司主营收入1.01亿元,同比上升8.94%;归母净利润2283.03万元,同比下降25.01%;扣非净利润2134.2万元,同比下降28.07%;负债率8.27%,投资收益109.58万元,财务费用-188.9万元,毛利率37.53%。新光药业主营业务:主要从事中成药、化学药、保健食品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081900013565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300519","BK0239","BK0132"],"gpt_icon":0},{"id":"2459110357","title":"新光药业(300519)8月14日主力资金净卖出107.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459110357","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459110357?lang=zh_cn&edition=full","pubTime":"2024-08-14 15:23","pubTimestamp":1723620202,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月14日收盘,新光药业报收于12.54元,下跌2.94%,换手率5.93%,成交量6.76万手,成交额8520.99万元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:新光药业2024年一季报显示,公司主营收入1.01亿元,同比上升8.94%;归母净利润2283.03万元,同比下降25.01%;扣非净利润2134.2万元,同比下降28.07%;负债率8.27%,投资收益109.58万元,财务费用-188.9万元,毛利率37.53%。新光药业主营业务:主要从事中成药、化学药、保健食品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081400027412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","300519"],"gpt_icon":0},{"id":"2458762706","title":"新光药业(300519)8月12日主力资金净买入1122.86万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458762706","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458762706?lang=zh_cn&edition=full","pubTime":"2024-08-12 15:18","pubTimestamp":1723447111,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月12日收盘,新光药业报收于13.12元,上涨6.93%,换手率11.48%,成交量13.09万手,成交额1.68亿元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:新光药业2024年一季报显示,公司主营收入1.01亿元,同比上升8.94%;归母净利润2283.03万元,同比下降25.01%;扣非净利润2134.2万元,同比下降28.07%;负债率8.27%,投资收益109.58万元,财务费用-188.9万元,毛利率37.53%。新光药业主营业务:主要从事中成药、化学药、保健食品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200013131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300519","BK0132","BK0239"],"gpt_icon":0},{"id":"2458532604","title":"新光药业(300519)8月9日主力资金净卖出1027.76万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458532604","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458532604?lang=zh_cn&edition=full","pubTime":"2024-08-09 15:24","pubTimestamp":1723188262,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月9日收盘,新光药业报收于12.27元,下跌4.14%,换手率8.1%,成交量9.24万手,成交额1.14亿元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:新光药业2024年一季报显示,公司主营收入1.01亿元,同比上升8.94%;归母净利润2283.03万元,同比下降25.01%;扣非净利润2134.2万元,同比下降28.07%;负债率8.27%,投资收益109.58万元,财务费用-188.9万元,毛利率37.53%。新光药业主营业务:主要从事中成药、化学药、保健食品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080900025831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300519","BK0239"],"gpt_icon":0},{"id":"2457860599","title":"新光药业(300519)8月7日主力资金净卖出384.18万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457860599","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457860599?lang=zh_cn&edition=full","pubTime":"2024-08-07 15:22","pubTimestamp":1723015355,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月7日收盘,新光药业报收于12.18元,下跌4.17%,换手率8.72%,成交量9.95万手,成交额1.22亿元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:新光药业2024年一季报显示,公司主营收入1.01亿元,同比上升8.94%;归母净利润2283.03万元,同比下降25.01%;扣非净利润2134.2万元,同比下降28.07%;负债率8.27%,投资收益109.58万元,财务费用-188.9万元,毛利率37.53%。新光药业主营业务:主要从事中成药、化学药、保健食品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080700026932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","300519"],"gpt_icon":0},{"id":"2457109878","title":"新光药业(300519)8月6日主力资金净买入582.90万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457109878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457109878?lang=zh_cn&edition=full","pubTime":"2024-08-06 15:17","pubTimestamp":1722928632,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月6日收盘,新光药业报收于12.71元,上涨6.54%,换手率12.81%,成交量14.62万手,成交额1.83亿元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:新光药业2024年一季报显示,公司主营收入1.01亿元,同比上升8.94%;归母净利润2283.03万元,同比下降25.01%;扣非净利润2134.2万元,同比下降28.07%;负债率8.27%,投资收益109.58万元,财务费用-188.9万元,毛利率37.53%。新光药业主营业务:主要从事中成药、化学药、保健食品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080600024841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","300519"],"gpt_icon":0},{"id":"2457706329","title":"A股中药股震荡走强,佛慈制药午后涨停,华森制药、维康药业、长药控股、健民集团涨超5%,新光药业、盘龙药业、大唐药业、粤万年青等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457706329","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457706329?lang=zh_cn&edition=full","pubTime":"2024-08-06 13:11","pubTimestamp":1722921103,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["002864","300878","301111","BK0188","BK0250","300519","BK0028","399300","002644","BK0086","159982","BK0077","600976","BK0239","BK0224","BK0209","BK0132","002907","300391"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2016-06-24","address":"浙江省绍兴市嵊州市剡湖街道环城西路25号","stockEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":-0.0472},{"period":"3month","weight":0.3019},{"period":"6month","weight":0.1994},{"period":"1year","weight":-0.0917},{"period":"ytd","weight":-0.0807}],"companyName":"浙江新光药业股份有限公司","boardCode":"AI0027","perCapita":"7081股","boardName":"医药制造业","registeredCapital":"16000万元","compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.1808},{"period":"6month","weight":0.0911},{"period":"1year","weight":0.1074},{"period":"ytd","weight":0.1329}],"survey":" 浙江新光药业股份有限公司的主营业务是中成药、化学药、保健食品的研发、生产和销售。公司主要产品以治疗心脑血管疾病、外伤科疾病和保健滋补为主,主要产品为黄芪生脉饮、伸筋丹胶囊、西洋参口服液等。由于公司对产品质量严格要求,公司主导产品黄芪生脉饮多次获得“浙江省名牌产品”称号和“中国中药名牌产品”称号,为公司赢得了良好的品牌形象。","serverTime":1732257664385,"listedPrice":12.2,"stockholders":"16112人(较上一季度增加1.00%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新光药业(300519)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新光药业(300519)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新光药业,300519,新光药业股票,新光药业股票老虎,新光药业股票老虎国际,新光药业行情,新光药业股票行情,新光药业股价,新光药业股市,新光药业股票价格,新光药业股票交易,新光药业股票购买,新光药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新光药业(300519)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新光药业(300519)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}